AxxessBio launched Caphosol® in Malaysia. Caphosol® is also available in Singapore and Brunei.
Caphosol® a topical oral agent, is a US patented medical device that lubricates the mucosa of the mouth, tongue and oropharynx and helps maintain the integrity of the oral cavity through its mineralizing potential. The distinguishing feature of Caphosol® is its high concentrations of calcium and phosphate ions.
Caphosol® is indicated as an adjunct to standard oral care in the prevention and treatment of the mucositis that may be caused by radiation or high dose chemotherapy. Relief of dryness of the oral mucosa in these conditions is associated with amelioration of pain.
Caphosol® is also indicated for dryness of the mouth and oropharynx (hyposalivation, xerostomia), regardless of the cause and regardless of whether the condition is temporary or permanent.
AxxessBio is the exclusive distributor of Caphosol® in Singapore, Malaysia and Brunei.